Susmed Overview
- Year Founded
-
2015
- Status
-
Public
- Employees
-
50
- Stock Symbol
-
4263
- Share Price
-
$1.58
- (As of Friday Closing)
Susmed General Information
Description
Susmed Inc is engaged in the development of therapeutic smartphone apps and digital solutions to streamline clinical trials. It is currently developing therapeutic apps for patients with insomnia, breast cancer, kidney disease, and other conditions. In addition, it has developed Susumed System, which uses a proprietary blockchain technology to ensure the reliability of clinical trial data, and can reduce the manpower and costs allocated to clinical trials. The company's reportable segments are: the DTx Product Business, which derives maximum revenue, and consists of the development of therapeutic apps; and the DTx Platform Business, which provides general-purpose clinical trial systems and machine learning automated analysis systems.
Contact Information
Website
www.susmed.co.jpCorporate Office
- MFPR Nihonbashi Honcho Building 10th Floor
- 3-7-2 Nihonbashi Honcho, Chuo-ku
- Tokyo, 103-0023
- Japan
Corporate Office
- MFPR Nihonbashi Honcho Building 10th Floor
- 3-7-2 Nihonbashi Honcho, Chuo-ku
- Tokyo, 103-0023
- Japan
Susmed Stock Performance
As of 13-Nov-2026, Susmed’s stock price is $1.58. Its current market cap is $26.6M with 16.9M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.58 | $1.54 | $1.51 - $7.73 | $26.6M | 16.9M | 155K | -$0.15 |
Susmed Financials Summary
As of 30-Jun-2026, Susmed has a trailing 12-month revenue of $3.22M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2026 30-Jun-2026 | FY 2025 30-Jun-2025 | FY 2024 30-Jun-2024 |
|---|---|---|---|---|
| EV | 65,838 | 65,838 | 39,614 | 31,631 |
| Revenue | 3,220 | 3,220 | 3,093 | 2,297 |
| EBITDA | (2,388) | (2,388) | (1,932) | (2,349) |
| Net Income | (2,478) | (2,478) | (1,994) | (2,397) |
| Total Assets | 26,049 | 26,049 | 31,151 | 30,649 |
Susmed Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Susmed Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
Susmed Patents
Susmed Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026159836-A1 | Thought transmission assistance system, thought transmission assistance device, and thought transmission assistance program | Pending | 23-Jan-2025 | ||
| WO-2026141050-A1 | Information processing device and application program | Pending | 24-Dec-2024 | ||
| WO-2026042718-A1 | Cognitive behavioral therapy assistance device, cognitive behavioral therapy assistance system, and cognitive behavioral therapy assistance program | Pending | 19-Aug-2024 | ||
| WO-2025248743-A1 | Llm utilization system, llm service provision device, and llm service provision method | Pending | 31-May-2024 | ||
| WO-2025203306-A1 | Treatment assistance device, treatment assistance program, and treatment assistance system | Pending | 27-Mar-2024 |
Susmed Signals
Susmed ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Susmed FAQs
-
When was Susmed founded?
Susmed was founded in 2015.
-
Where is Susmed headquartered?
Susmed is headquartered in Tokyo, Japan.
-
What is the size of Susmed?
Susmed has 50 total employees.
-
What industry is Susmed in?
Susmed’s primary industry is Other Healthcare Technology Systems.
-
Is Susmed a private or public company?
Susmed is a Public company.
-
What is Susmed’s stock symbol?
The ticker symbol for Susmed is 4263.
-
What is the current stock price of Susmed?
As of 13-Nov-2026 the stock price of Susmed is $1.58.
-
What is the current market cap of Susmed?
The current market capitalization of Susmed is $26.6M.
-
What is Susmed’s current revenue?
The trailing twelve month revenue for Susmed is $3.22M.
-
What is Susmed’s annual earnings per share (EPS)?
Susmed’s EPS for 12 months was -$0.15.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process